Drug name - Onsolis

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9597288 BDSI Transmucosal delivery devices with enhanced uptake Jul, 2027

(4 years from now)

Drugs and Companies using FENTANYL CITRATE ingredient

Treatment: Management of breakthrough pain in patients with cancer

Dosage: FILM;BUCCAL

More Information on Dosage
Strength Dosage Availability
EQ 0.2MG BASE FILM;BUCCAL Discontinued
EQ 0.4MG BASE FILM;BUCCAL Discontinued
EQ 0.6MG BASE FILM;BUCCAL Discontinued
EQ 0.8MG BASE FILM;BUCCAL Discontinued
EQ 1.2MG BASE FILM;BUCCAL Discontinued

availability in other generic markets.

Click on the highlighted region to filter.